Evidence map›Paper›PMID 37112848›Full record

ArticleViruses2023

Genome Characterization and Infectivity Potential of Vibriophage-ϕLV6 with Lytic Activity against Luminescent Vibrios of

Manikantha Benala, Murugadas Vaiyapuri, Visnuvinayagam Sivam, Karthika Raveendran, Mukteswar Prasad Mothadaka, Madhusudana Rao Badireddy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Characterization of a Vibriophage Infecting PathogenicInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Manikantha BenalaVisakhapatnam Research Centre of ICAR-Central Institute of Fisheries Technology (ICAR-CIFT), Visakhapatnam 530003, India.ORCID 0000-0002-0381-569X
Murugadas VaiyapuriICAR-Central Institute of Fisheries Technology (ICAR-CIFT), Willingdon Island, Cochin 682029, India.ORCID 0000-0001-5807-9290
Visnuvinayagam SivamICAR-Central Institute of Fisheries Technology (ICAR-CIFT), Willingdon Island, Cochin 682029, India.
Karthika RaveendranICAR-Central Institute of Fisheries Technology (ICAR-CIFT), Willingdon Island, Cochin 682029, India.
Mukteswar Prasad MothadakaVisakhapatnam Research Centre of ICAR-Central Institute of Fisheries Technology (ICAR-CIFT), Visakhapatnam 530003, India.ORCID 0000-0003-1104-7501
Madhusudana Rao BadireddyVisakhapatnam Research Centre of ICAR-Central Institute of Fisheries Technology (ICAR-CIFT), Visakhapatnam 530003, India.ORCID 0000-0003-1154-9210
Central Institute of Fisheries Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shrimp aquaculture, especially during the hatchery phase, is prone to economic losses due to infections caused by luminescent vibrios. In the wake of antimicrobial resistance (AMR) in bacteria and the food safety requirements of farmed shrimp, aqua culturists are seeking alternatives to antibiotics for shrimp health management, and bacteriophages are fast emerging as natural and bacteria-specific antimicrobial agents. This study analyzed the whole genome of vibriophage-ϕLV6 that showed lytic activity against six luminescent vibrios isolated from the larval tanks of

Indexed as

BacteriophagesPenaeidaeVibrioAnimalsAquacultureIndiacomparative genomicsluminescent vibriosPenaeus vannameiphage therapyVibrio harveyivibriophagewhole genome sequence

Identifiers

PMID37112848
PMCPMC10141217
OpenAlexW4361289331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.